Improvement of insulin sensitivity and dyslipidemia with a new α- glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects

Metabolism: Clinical and Experimental

Volumn 45, Issue 6, 1996, Pages 731-737

  Shinozaki, Kazuya ^b   Suzuki, Masaaki ^b   Ikebuchi, Motoyoshi ^b   Hirose, Junya ^b   Hara, Yasushi ^b   Harano, Yutaka ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VOGLIBOSE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINISM; HYPOINSULINEMIA; INSULIN BINDING; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR; STEADY STATE; TEST MEAL;

EID: 0029886788     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90139-0     Document Type: Article

References (42)

1. Stout RW: Insulin and atheroma - 20 yr perspective. Diabetes Care 13:631-654, 1990
2. Pyörälä K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care 2:131-141, 1979
3. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes 2:154-160, 1979
4. Ducimetiere P, Eschwege E, Papoz L, et al: Relationship of plasma insulin level to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
5. Logan RL, Riemersma RA, Thomson M, et al: Risk factors for ischaemic heart disease in normal men aged 40: Edinburgh-Stockholm study. Lancet 1:949-955, 1978
6. Rubenstein AH, Seftel HC, Miller K, et al: Metabolic response to oral glucose in healthy South African white, Indian, and African subjects. Br Med J 1:748-751, 1969
7. Defronzo RA, Ferrannini E: Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
8. Shinozaki K, Suzuki M, Ikebuchi M, et al: Demonstration of insulin resistance in coronary artery disease documented with angiography. Diabetes Care 19:1-7, 1996
9. Shinozaki K, Suzuki M, Ikebuchi M, et al: Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 92:1749-1757, 1995
10. Bodardus C, Ravussin E, Robbins DC, et al: Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes 33:311-318, 1984
11. Pedersen O, Hjollund E, Lindskov HO, et al: Increased insulin receptor binding to monocytes from insulin-dependent diabetic patients after a low-fat, high-starch, high-fiber diet. Diabetes Care 5:284-291, 1982
12. Horii S, Fukase H, Matsuo T, et al: Synthesis and α-D-glucosidase activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents. J Med Chem 29:1038-1046, 1986
13. Odaka H, Miki N, Ikeda H, et al: Effect of a disaccharidase inhibitor, AO-128, on postprandial hyperglycemia in rats. J Jpn Soc Nutr Food Sci 45:27-31, 1992
14. Landinois CK, Greenfield MS, Schwartz HC, et al: Acarbose treatment of non-insulin-dependent diabetes mellitus. Arch Intern Med 144:345-347, 1984
15. Samad AHB, Willing TST, Alberti KGMM, et al: Effects of BAYm 1099, new α-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo. Diabetes Care 11:337-344, 1988
16. WHO Study Group: Definition, diagnosis, and classification. Diabetes mellitus. Report of a WHO Study Group. WHO Tech Rep Ser 727:9-25, 1985
17. Hoffman WS: A rapid photoelectric method for the determination of glucose in blood and urine. J Biol Chem 120:52-55, 1937
18. Hale CN, Randle PJ: Immunoassay of insulin with insulinantibody precipitate. Biochem J 88:137-146, 1963
19. Nathan DM, Dunn BS, Francis TB: Two commercial methods evaluated for eliminating the labile fraction from the assay for glycated hemoglobin (glycohemoglobin). Clin Chem 30:109-110, 1984
20. Richmond W: Preparation and properties of a cholesterol oxidase from Nacardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19:1350-1356, 1973
21. Fletcher MJ: A calorimetric method for estimating serum triglycerides. Clin Chim Acta 22:393-397, 1968
22. Didez LI: Separation and quantitation of subclasses of human plasma high density lipoproteins by a single precipitation procedure. J Lipid Res 23:1206-1223, 1982
23. Mancini G, Carbonara AO, Heremans JF: Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochem 2:235-40, 1965
24. Harano Y, Kageyama A, Hirose J, et al: Improvement of insulin sensitivity for glucose metabolism with long-acting Ca channel blocker, Amlodipine, in essential hypertensive subjects. Metabolism 44:315-319, 1995
25. Harano Y, Hidaka H, Takatsuki K, et al: Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism 27:1449-1452, 1978
26. Harada M, Harano Y, Kojima H, et al: Computerized glucose clamp method for the determination of insulin sensitivity in diabetic subjects. Jpn J Med 26:25-30, 1987
27. Lembcke B, Fölsch UR, Gatzemeier W, et al: Inhibition of sucrose- and starch-induced glycemic and hormonal responses by the α-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers. Eur J Clin Pharmacol 41:561-567, 1991
28. Hayakawa T, Kondo T, Okumura N, et al: Enteroglucagon release in disaccharide malabsorption induced by intestinal α-glucosidase inhibition. Am J Gastroenterol 84:523-526, 1989
29. Caspary WF, Graf S: Inhibition of human intestinal alpha-glucosidehydrolase by a new complex oligosaccharide. Res Exp Med (Berl) 175:1-176, 1979
30. Walton RJ, Sherif IT, Noy GA, et al: Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor. Br Med J 1:220-221, 1979
31. Uttenthal LO, Ukponmwan OO, Wood SM, et al: Longterm effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas. Diabetic Med 3:155-160, 1986
32. Fujioka S, Matsuzawa Y, Tokunaga K, et al: Treatment of visceral obesity. Int J Obes 15:59-65, 1991
33. Baron AD, Eckel RH, Schmeiser L, et al: The effect of short-term α-glucosidase inhibition on carbohydrate and lipid metabolism in type II (noninsulin-dependent) diabetics. Metabolism 36:409-415, 1987
34. Jenney A, Proietto J, O'Dea K, et al: Low-dose acarbose improves glycemic control in NIDDM patients without changes in insulin sensitivity. Diabetes Care 16:499-502, 1993
35. Folsch UR, Ebert R, Creutzfeldt W: Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose. Scand J Gastroenterol 16:629-632, 1981
36. Fukase N, Takahashi H, Manaka H, et al: Differences in glucagon-like peptide-1 and GIP response following sucrose ingestion. Diabetes Res Clin Pract 15:187-195, 1992
37. Bar RS, Gorden P, Roth J, et al: Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients. J Clin Invest 58:1123-1135, 1976
38. Reaven GM, Lerner RL, Stern MM: Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46:1756-1767, 1967
39. Sadur CN, Eckel RH: Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique. J Clin Invest 69:1119-1125, 1982
40. Zavaroni I, Dall'Aglio E, Alpi O: Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55:259-266, 1985
41. Stalder M, Pometta B, Suenram A: Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia 21:544-548, 1981
42. Clissold SP, Edwards C: Acarbose - A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 35:214-243, 1988